BR9908392A - Uso de antagonistas de d1/d5 para o tratamento de distúrbios obsessivos compulsivos, distúrbios somatofórmicos, distúrbios dissociativos, distúrbios de alimentação, distúrbios de controle de impulsos e autismo - Google Patents

Uso de antagonistas de d1/d5 para o tratamento de distúrbios obsessivos compulsivos, distúrbios somatofórmicos, distúrbios dissociativos, distúrbios de alimentação, distúrbios de controle de impulsos e autismo

Info

Publication number
BR9908392A
BR9908392A BR9908392-2A BR9908392A BR9908392A BR 9908392 A BR9908392 A BR 9908392A BR 9908392 A BR9908392 A BR 9908392A BR 9908392 A BR9908392 A BR 9908392A
Authority
BR
Brazil
Prior art keywords
disorders
treatment
dissociative
autism
antagonists
Prior art date
Application number
BR9908392-2A
Other languages
English (en)
Inventor
Vicki L Coffin
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of BR9908392A publication Critical patent/BR9908392A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Patente de Invenção: <B>"USO DE ANTAGONISTAS DE D1/D5 PARA O TRATAMENTO DE DISTúRBIOS OBSESSIVOS COMPULSIVOS, DISTúRBIOS SOMATOFóRMICOS, DISTúRBIOS DISSOCIATIVOS, DISTúRBIOS DE ALIMENTAçãO, DISTúRBIOS DE CONTROLE DE IMPULSOS E AUTISMO"<D>. é descrito um método para o tratamento de distúrbios obsessivos compulsivos, distúrbios somatofórmicos, distúrbios dissociativos, distúrbios de alimentação, distúrbios do controle de impulsos e autismo. Os distúrbios são tratados pela administração de uma quantidade eficaz de um antagonista de D1/D5.
BR9908392-2A 1998-03-02 1999-03-01 Uso de antagonistas de d1/d5 para o tratamento de distúrbios obsessivos compulsivos, distúrbios somatofórmicos, distúrbios dissociativos, distúrbios de alimentação, distúrbios de controle de impulsos e autismo BR9908392A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3320598A 1998-03-02 1998-03-02
PCT/US1999/003721 WO1999044615A1 (en) 1998-03-02 1999-03-01 Use of d1/d5 antagonists for treating obsessive compulsive disorders, somatoform disorders, dissociative, eating disorders, impulse control disorders and autism

Publications (1)

Publication Number Publication Date
BR9908392A true BR9908392A (pt) 2000-10-31

Family

ID=21869083

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9908392-2A BR9908392A (pt) 1998-03-02 1999-03-01 Uso de antagonistas de d1/d5 para o tratamento de distúrbios obsessivos compulsivos, distúrbios somatofórmicos, distúrbios dissociativos, distúrbios de alimentação, distúrbios de controle de impulsos e autismo

Country Status (16)

Country Link
EP (1) EP1058551A1 (pt)
JP (1) JP2002505291A (pt)
KR (1) KR20010041477A (pt)
CN (1) CN1291893A (pt)
AR (1) AR018297A1 (pt)
AU (1) AU2778099A (pt)
BR (1) BR9908392A (pt)
CA (1) CA2322201A1 (pt)
CO (1) CO4910136A1 (pt)
HU (1) HUP0101057A3 (pt)
IL (1) IL137715A0 (pt)
NO (1) NO20004363L (pt)
PE (1) PE20000333A1 (pt)
SK (1) SK12962000A3 (pt)
WO (1) WO1999044615A1 (pt)
ZA (1) ZA991638B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410527B1 (en) * 1998-03-02 2002-06-25 Schering Corporation Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders, and autism
RU2374245C1 (ru) 2008-08-22 2009-11-27 Андрей Александрович Иващенко Лиганд с широким спектром одновременной рецепторной активности, фармацевтическая композиция, способ ее получения и лекарственное средство
PT2872145T (pt) * 2012-07-12 2022-05-26 Emalex Biosciences Inc Benzazepinas fundidas para o tratamento da síndrome de tourette

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605897A (en) * 1991-04-23 1997-02-25 Eli Lilly And Company 2-methyl-thieno-benzodiazepine
EP1043980A2 (en) * 1997-10-28 2000-10-18 Schering Corporation Method of reducing craving in mammals

Also Published As

Publication number Publication date
ZA991638B (en) 1999-09-01
WO1999044615A1 (en) 1999-09-10
HUP0101057A3 (en) 2001-09-28
AU2778099A (en) 1999-09-20
PE20000333A1 (es) 2000-05-13
IL137715A0 (en) 2001-10-31
CA2322201A1 (en) 1999-09-10
JP2002505291A (ja) 2002-02-19
HUP0101057A2 (hu) 2001-08-28
CO4910136A1 (es) 2000-04-24
NO20004363L (no) 2000-10-31
KR20010041477A (ko) 2001-05-25
NO20004363D0 (no) 2000-09-01
AR018297A1 (es) 2001-11-14
SK12962000A3 (sk) 2001-08-06
EP1058551A1 (en) 2000-12-13
CN1291893A (zh) 2001-04-18

Similar Documents

Publication Publication Date Title
TR200101859T2 (tr) Kemokin alıcı aktivitesinin modülatörleri olarak N-üreidoalkil-piperidinler
BR9813028A (pt) Agonistas de prostaglandina e seu uso para tratar distúrbios nos ossos
EA200300717A1 (ru) Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
DE69732868D1 (de) Mittel gegen Juckreiz
TR200102021T2 (tr) TWEAK ve TWEAK reseptörü antagonistleri ve bunların imünolojik bozuklukların iyileştirilmesi için kullanımları
DE69925571D1 (de) Sulphonamid-derivate zur behandlung von störungen des zentralnervensystems
ATE302606T1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
BR9812357A (pt) Tratamento de distúbio oposicional desafiador
NO20035025L (no) Anvendelse av osteopontin for behandling og/eller for a hindre nevrologiske sykdommer, samt farmasoytisk sammensetning omfattende osteopontin eller en antagonist med osteopontinaktivitet.
BR9812371A (pt) Tratamento de distúrbio de conduta
BR0111913A (pt) Análogos de gabapentina para distúrbios do sono
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
DE60206164D1 (de) Trisubstituierte-n-((1s)-1,2,3,4-tetrahydro-1-naphthalenyl) benzamide welche p2x3 und p2x2/3 enthaltende rezeptoren inhibieren
NZ334029A (en) Use of serotonin 5-HT1F agonist for the treatment of common colds or allergic rhinitis
DK1578740T3 (da) 1,2,4-triaminobenzenderivater, der er egnede til behandling af lidelser i centralnervesystemet
BRPI0411864A (pt) combinação de inibidores de src quinase e agentes quimioterápicos para o tratamento de doenças proliferativas
EA200301143A1 (ru) Производные гетероциклилалкокси-, алкилтио- и -алкиламинобензазола в качестве лигандов 5-гидрокситриптамина-6
WO2000002551A3 (en) Methods and compounds for treating depression
EE200200632A (et) Glükokortikoidravimeid sisaldavad preparaadid bronhopulmonaalsete haiguste raviks
TR200101149T2 (tr) Dış retina bozukluklarının tedavisi.
EP1422240A3 (en) Analogs of nociceptin
BR0214643A (pt) Aplicação de um antagonista h1, e um esteróide seguro para tratar rinite
DE69917005D1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
BR9908392A (pt) Uso de antagonistas de d1/d5 para o tratamento de distúrbios obsessivos compulsivos, distúrbios somatofórmicos, distúrbios dissociativos, distúrbios de alimentação, distúrbios de controle de impulsos e autismo
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTA A 5O, 6O, 7O E 8O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007.